GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹249 Cr | ₹247 Cr | ₹255 Cr | ₹262 Cr | ₹259 Cr |
What is the latest Long Term Provisions ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹249 Cr |
| Mar2024 | ₹247 Cr |
| Mar2023 | ₹255 Cr |
| Mar2022 | ₹262 Cr |
| Mar2021 | ₹259 Cr |
How is Long Term Provisions of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹249 Cr | 0.66 | |
| Mar2024 | ₹247 Cr | -2.88 | |
| Mar2023 | ₹255 Cr | -2.83 | |
| Mar2022 | ₹262 Cr | 1.05 | |
| Mar2021 | ₹259 Cr | - | |
Compare Long Term Provisions of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,067.9 Cr | 0.3% | -1.5% | 9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 0.3% |
-1.5% |
9% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses